Apellis Pharmaceuticals Inc (APLS)
47.53
+0.02
(+0.04%)
USD |
NASDAQ |
Apr 19, 16:00
47.53
0.00 (0.00%)
After-Hours: 19:26
Apellis Pharmaceuticals Market Cap: 5.731B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 18, 2024 | 5.729B |
April 17, 2024 | 5.792B |
April 16, 2024 | 6.249B |
April 15, 2024 | 6.210B |
April 12, 2024 | 6.245B |
April 11, 2024 | 6.720B |
April 10, 2024 | 6.854B |
April 09, 2024 | 6.646B |
April 08, 2024 | 6.489B |
April 05, 2024 | 6.742B |
April 04, 2024 | 6.759B |
April 03, 2024 | 6.867B |
April 02, 2024 | 6.716B |
April 01, 2024 | 7.200B |
March 28, 2024 | 7.088B |
March 27, 2024 | 7.053B |
March 26, 2024 | 7.114B |
March 25, 2024 | 6.696B |
March 22, 2024 | 6.679B |
March 21, 2024 | 6.826B |
March 20, 2024 | 6.695B |
March 19, 2024 | 6.864B |
March 18, 2024 | 6.784B |
March 15, 2024 | 6.842B |
March 14, 2024 | 6.810B |
Date | Value |
---|---|
March 13, 2024 | 6.917B |
March 12, 2024 | 7.054B |
March 11, 2024 | 7.318B |
March 08, 2024 | 7.431B |
March 07, 2024 | 7.529B |
March 06, 2024 | 7.348B |
March 05, 2024 | 7.533B |
March 04, 2024 | 7.793B |
March 01, 2024 | 7.704B |
February 29, 2024 | 7.472B |
February 28, 2024 | 7.723B |
February 27, 2024 | 8.362B |
February 26, 2024 | 8.649B |
February 23, 2024 | 8.256B |
February 22, 2024 | 8.150B |
February 21, 2024 | 8.066B |
February 20, 2024 | 8.181B |
February 16, 2024 | 8.223B |
February 15, 2024 | 8.080B |
February 14, 2024 | 8.057B |
February 13, 2024 | 7.911B |
February 12, 2024 | 8.100B |
February 09, 2024 | 8.197B |
February 08, 2024 | 8.144B |
February 07, 2024 | 7.974B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.138B
Minimum
May 17 2019
10.87B
Maximum
Jun 13 2023
4.472B
Average
4.173B
Median
Jan 07 2021
Market Cap Benchmarks
Sarepta Therapeutics Inc | 10.84B |
Blueprint Medicines Corp | 5.319B |
Alnylam Pharmaceuticals Inc | 18.19B |
Ionis Pharmaceuticals Inc | 5.925B |
Madrigal Pharmaceuticals Inc | 4.220B |
Market Cap Related Metrics
PS Ratio | 14.22 |
Price to Book Value | 29.46 |
Price | 47.53 |
Earnings Yield | -9.43% |